Cargando…

The Cost-Effectiveness of Continuous Erythropoiesis Receptor Activator Once Monthly versus Epoetin Thrice Weekly for Anaemia Management in Chronic Haemodialysis Patients

Introduction. The aim of this study was to compare the cost-effectiveness of continuous erythropoietin receptor activator (CERA) once monthly to epoetin beta (EpoB) thrice weekly to maintain haemoglobin (Hb) within the range 10.5–12 g/dL. Methods. Prospective cohort study and cost-effectiveness anal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maoujoud, Omar, Ahid, Samir, Dkhissi, Hocein, Oualim, Zouhair, Cherrah, Yahia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710935/ https://www.ncbi.nlm.nih.gov/pubmed/26843983 http://dx.doi.org/10.1155/2015/189404

Ejemplares similares

The cost-utility of treating anemia with continuous erythropoietin receptor activator or Epoetin versus routine blood transfusions among chronic hemodialysis patients
por: Maoujoud, Omar, et al.
Publicado: (2016)

Cost-Minimization Analysis of Once-Weekly Versus Thrice-Weekly Epoetin Alfa for Chemotherapy-Related Anemia
por: Cremieux, Pierre Y., et al.
Publicado: (2004)

Once-monthly continuous erythropoietin receptor activator (CERA) for haemoglobin maintenance in haemodialysis patients with chronic renal anaemia
por: Duman, Neval, et al.
Publicado: (2014)

Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial
por: Carrera, Fernando, et al.
Publicado: (2010)

The Coronavirus Disease 2019 (COVID-19) Pandemic in Africa: What Can We Expect?
por: Maoujoud, Omar, et al.
Publicado: (2020)

Comparison of different dosing regimens (once weekly vs. twice weekly, and once weekly vs. once every two weeks) with epoetin delta in patients with chronic kidney disease: a randomized controlled trial
por: Macdougall, Iain C
Publicado: (2007)

A proposal of the simple guide regarding the conversion ratio from epoetin to darbepoetin alpha in treating haemodialysis patients with renal anaemia
por: Nakagawa, Tetsuya
Publicado: (2008)

Efficacy of once or twice weekly administration of epoetin κ in patients receiving hemodialysis: A retrospective study
por: OHTA, SHOICHIRO, et al.
Publicado: (2014)

The Prevalence of Thrice, Twice, and Once Human Papillomavirus DNA Positivity in Older Chinese Women
por: Hu, Guomin, et al.
Publicado: (2020)

Tuberculous meningitis on directly observed thrice a week regime
por: Yasri, Sora, et al.
Publicado: (2015)

Anaemia management with subcutaneous epoetin delta in patients with chronic kidney disease (predialysis, haemodialysis, peritoneal dialysis): results of an open-label, 1-year study
por: Frei, Ulrich, et al.
Publicado: (2009)

Renal replacement treatment initiation with twice-weekly versus thrice-weekly haemodialysis in patients with incident dialysis-dependent kidney disease: rationale and design of the TWOPLUS pilot clinical trial
por: Murea, Mariana, et al.
Publicado: (2021)

Once Versus Thrice Daily Colistin in Critically Ill Ptients with Multi-Drug Resistant Infections
por: Ghazaeian, Monireh, et al.
Publicado: (2017)

A Comparison of Practice Pattern and Outcome of Twice-weekly and Thrice-weekly Hemodialysis Patients
por: Mukherjee, T., et al.
Publicado: (2017)

Factors influencing anti-asthmatic generic drug consumption in Morocco: 1999-2010
por: Ghanname, Imane, et al.
Publicado: (2014)

Thrice-Weekly Nocturnal In-Centre Haemodiafiltration: A 2-Year Experience
por: Dey, Vishal, et al.
Publicado: (2015)

24 Improved Dialysis Symptom Index with Tablo Thrice Weekly Dialysis
Publicado: (2021)

A randomized controlled trial of thrice-weekly versus thrice-daily oral ferrous fumarate treatment in adult patients with iron-deficiency anemia
por: Jongkraijakra, Siddhibhong, et al.
Publicado: (2023)

The NightLife study — the clinical and cost-effectiveness of thrice-weekly, extended, in-centre nocturnal haemodialysis versus daytime haemodialysis using a mixed methods approach: study protocol for a randomised controlled trial
por: Hull, Katherine L., et al.
Publicado: (2023)

Pure red cell aplasia after treatment of renal anaemia with epoetin theta
por: Herrington, W., et al.
Publicado: (2013)

Treatment outcomes of drug resistant tuberculosis patients in Morocco: multi-centric prospective study
por: El Hamdouni, Mariam, et al.
Publicado: (2019)

Comparison of Clinical Outcome Between Twice-Weekly and Thrice-Weekly Hemodialysis in Patients With Residual Kidney Function
por: Hwang, Hyeon Seok, et al.
Publicado: (2016)

Anakinra for patients with COVID-19
por: Maoujoud, Omar, et al.
Publicado: (2020)

Major outcomes of patients with tuberculous meningitis on directly observed thrice a week regime
por: Iype, Thomas, et al.
Publicado: (2014)

SARS-CoV-2 Antigen Testing Intervals: Twice or Thrice a Week?
por: Lau, Chin Shern, et al.
Publicado: (2022)

Saccharated ferric oxide attenuates haematopoietic response induced by epoetin beta pegol in patients undergoing haemodialysis
por: Iwasaki, Takahide, et al.
Publicado: (2021)

Monthly cost of three exchanges a day peritoneal dialysis is same as of thrice a week hemodialysis in self-paying Indian patients
por: Jeloka, T. K., et al.
Publicado: (2012)

Profil épidémiologique de l'insuffisance rénale terminale à l'hôpital Militaire de Rabat, Maroc
por: Asserraji, Mohammed, et al.
Publicado: (2015)

Twice or Thrice Weekly versus Daily Thyroxine in Hypothyroid Fasting Ramadan: A Pilot Study
por: Elsherbiny, Tamer Mohamed
Publicado: (2022)

Compliance with Once-Daily versus Twice or Thrice-Daily Administration of Antibiotic Regimens: A Meta-Analysis of Randomized Controlled Trials
por: Falagas, Matthew E., et al.
Publicado: (2015)

Randomized Clinical Trial of Thrice-Weekly 4-Month Moxifloxacin or Gatifloxacin Containing Regimens in the Treatment of New Sputum Positive Pulmonary Tuberculosis Patients
por: Jawahar, Mohideen S., et al.
Publicado: (2013)

Randomised, phase III trial of epoetin-β to treat chemotherapy-induced anaemia according to the EU regulation
por: Fujisaka, Y, et al.
Publicado: (2011)

The anaemia treatment journey of CKD patients: from epoetins to hypoxia-inducible factor-prolyl hydroxylase inhibitors
por: Locatelli, Francesco, et al.
Publicado: (2023)

Glomerular diseases in the Military Hospital of Morocco: Review of a single centre renal biopsy database on adults
por: Aatif, T., et al.
Publicado: (2012)

Growth hormone replacement therapy in adults with growth hormone deficiency; thrice weekly low dose administration.
por: Chung, Y. S., et al.
Publicado: (1994)

Efficacy and safety of thrice weekly DOTS in tuberculosis patients with and without HIV co-infection: an observational study
por: Vashishtha, Richa, et al.
Publicado: (2013)

Evaluation of a thrice weekly administration of teicoplanin in the outpatient setting: a retrospective observational multicentre study
por: Asumang, John, et al.
Publicado: (2021)

Regression of left ventricular mass following conversion from conventional hemodialysis to thrice weekly in-centre nocturnal hemodialysis
por: Wald, Ron, et al.
Publicado: (2012)

Intradialytic Symptoms and Recovery Time in Patients on Thrice-Weekly In-Center Hemodialysis: A Cross-sectional Online Survey
por: Alvarez, Luis, et al.
Publicado: (2019)

Intravenous iron and erythropoiesis‐stimulating agents in haemodialysis: A systematic review and meta‐analysis
por: Roger, Simon D, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uc7jq4129vcutmth38c1oebbih